Leslie Molony

Transgeneron Therapeutics, Inc. researches and develops therapies to treat diseases. It develops therapeutic medicine that promotes tissue regeneration by reprogramming healthy tissue. This therapeutic reprogramming causes cells to 'trans-differentiate' into cells that can replace diseased or degenerated organs. The company was founded in April 2007 and is located in Gainesville, FL

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA.

EDB Business Partner ASA engages in the sale of software, information technology solutions and consulting services, as well as the centralized and decentralized operation of computer systems. It also offers outsourcing services and services related to data communication, data security and electronic publishing. The company was founded in 1961 and is headquartered in Oslo, Norway

ProPharma Partners Ltd. provides pharmaceutical and biotechnological consulting services. It helps its clients to develop and implement their strategic, business development, and clinical plans. The company is headquartered in Crawley, the United Kingdom.

Part of Deloitte LLP (New York), Recombinant Capital, Inc. is a company that provides life sciences subscription database and advisory services. The company is based in Walnut Creek, CA. The company was founded by Mark G. Edwards. Recombinant Capital was acquired by Deloitte Touche Tohmatsu Services LLC on June 16, 2008.

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL.